Follow the people · Insider
Fred B. Davenport Jr.
Fred B. Davenport Jr. files insider transactions with the SEC as a director of Medpace Holdings (MEDP). We hold 1 disclosed purchase or sale filed since 15 February 2006, 1 of them in the last 90 days.
- Files forMEDP
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure21 August 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 13 August 2018 — 19 August 2026Director · Medpace Holdings (MEDP)23 Form 4 lines · source: SEC Form 4
- Filed 14 February 2006 — 18 December 2006President · Pharmaceutical Product Development (PPDI)119 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 1,903 shares of Medpace HoldingsSEC Form 421 August 2026Common Stock · traded 19 August 2026 · filed 21 August 2026
- exercised options over 3,858 shares of Medpace HoldingsSEC Form 421 August 2026Common Stock · traded 19 August 2026 · filed 21 August 2026
- exercised options over 1,822 shares of Medpace HoldingsSEC Form 421 August 2026Common Stock · traded 19 August 2026 · filed 21 August 2026
- ▼ sold on the open market 7,283 shares of Medpace HoldingsSEC Form 421 August 2026Common Stock · traded 19 August 2026 · filed 21 August 2026
- exercised options over 1,903 shares of Medpace Holdings (a derivative holding)SEC Form 421 August 2026Stock Option (Right to Buy) · traded 19 August 2026 · filed 21 August 2026
- exercised options over 3,858 shares of Medpace Holdings (a derivative holding)SEC Form 421 August 2026Stock Option (Right to Buy) · traded 19 August 2026 · filed 21 August 2026
- exercised options over 1,822 shares of Medpace Holdings (a derivative holding)SEC Form 421 August 2026Stock Option (Right to Buy) · traded 19 August 2026 · filed 21 August 2026
- was granted 1,110 shares of Medpace Holdings (a derivative holding)SEC Form 418 May 2026Stock Option (Right to Buy) · traded 15 May 2026 · filed 18 May 2026
- exercised options over 6,472 shares of Medpace Holdings (a derivative holding)SEC Form 43 November 2025Stock Option (Right to Buy) · traded 30 October 2025 · filed 3 November 2025
- exercised options over 6,472 shares of Medpace HoldingsSEC Form 43 November 2025Common Stock · traded 30 October 2025 · filed 3 November 2025
- ▼ sold on the open market 5,972 shares of Medpace HoldingsSEC Form 43 November 2025Common Stock · traded 30 October 2025 · filed 3 November 2025
- was granted 1,224 shares of Medpace Holdings (a derivative holding)SEC Form 420 May 2025Stock Option (Right to Buy) · traded 16 May 2025 · filed 20 May 2025
- exercised options over 4,710 shares of Medpace Holdings (a derivative holding)SEC Form 428 April 2025Stock Option (Right to Buy) · traded 24 April 2025 · filed 28 April 2025
- exercised options over 4,710 shares of Medpace HoldingsSEC Form 428 April 2025Common Stock · traded 24 April 2025 · filed 28 April 2025
- ▼ sold on the open market 1,712 shares of Medpace HoldingsSEC Form 428 April 2025Common Stock · traded 24 April 2025 · filed 28 April 2025
- was granted 953 shares of Medpace Holdings (a derivative holding)SEC Form 421 May 2024Stock Option (Right to Buy) · traded 17 May 2024 · filed 21 May 2024
- was granted 1,769 shares of Medpace Holdings (a derivative holding)SEC Form 423 May 2023Stock Option (Right to Buy) · traded 19 May 2023 · filed 23 May 2023
- was granted 1,903 shares of Medpace Holdings (a derivative holding)SEC Form 424 May 2022Stock Option (Right to Buy) · traded 20 May 2022 · filed 24 May 2022
- ▲ bought on the open market 500 shares of Medpace HoldingsSEC Form 422 February 2022Common Stock · traded 17 February 2022 · filed 22 February 2022
- was granted 1,822 shares of Medpace Holdings (a derivative holding)SEC Form 418 May 2021Stock Option (Right to Buy) · traded 14 May 2021 · filed 18 May 2021
- was granted 3,858 shares of Medpace Holdings (a derivative holding)SEC Form 419 May 2020Stock Option (Right to Buy) · traded 15 May 2020 · filed 19 May 2020
- was granted 6,472 shares of Medpace Holdings (a derivative holding)SEC Form 421 May 2019Stock Option (Right to Buy) · traded 17 May 2019 · filed 21 May 2019
- was granted 4,710 shares of Medpace Holdings (a derivative holding)SEC Form 415 August 2018Stock Option (Right to Buy) · traded 13 August 2018 · filed 15 August 2018
- exercised options over 26,667 shares of Pharmaceutical Product Development (a derivative holding)SEC Form 419 December 2006Stock Options (to buy) · traded 18 December 2006 · filed 19 December 2006
- exercised options over 42,500 shares of Pharmaceutical Product Development (a derivative holding)SEC Form 419 December 2006Stock Options (to buy) · traded 18 December 2006 · filed 19 December 2006
- exercised options over 26,667 shares of Pharmaceutical Product DevelopmentSEC Form 419 December 2006Common Stock · traded 18 December 2006 · filed 19 December 2006
- exercised options over 42,500 shares of Pharmaceutical Product DevelopmentSEC Form 419 December 2006Common Stock · traded 18 December 2006 · filed 19 December 2006
- ▼ sold on the open market 1,400 shares of Pharmaceutical Product DevelopmentSEC Form 419 December 2006Common Stock · traded 18 December 2006 · filed 19 December 2006
- ▼ sold on the open market 100 shares of Pharmaceutical Product DevelopmentSEC Form 419 December 2006Common Stock · traded 18 December 2006 · filed 19 December 2006
- ▼ sold on the open market 700 shares of Pharmaceutical Product DevelopmentSEC Form 419 December 2006Common Stock · traded 18 December 2006 · filed 19 December 2006
- ▼ sold on the open market 3,075 shares of Pharmaceutical Product DevelopmentSEC Form 419 December 2006Common Stock · traded 18 December 2006 · filed 19 December 2006
- ▼ sold on the open market 21,625 shares of Pharmaceutical Product DevelopmentSEC Form 419 December 2006Common Stock · traded 18 December 2006 · filed 19 December 2006
- ▼ sold on the open market 10,481 shares of Pharmaceutical Product DevelopmentSEC Form 419 December 2006Common Stock · traded 18 December 2006 · filed 19 December 2006
- ▼ sold on the open market 9,413 shares of Pharmaceutical Product DevelopmentSEC Form 419 December 2006Common Stock · traded 18 December 2006 · filed 19 December 2006
- ▼ sold on the open market 2,898 shares of Pharmaceutical Product DevelopmentSEC Form 419 December 2006Common Stock · traded 18 December 2006 · filed 19 December 2006
- ▼ sold on the open market 16,604 shares of Pharmaceutical Product DevelopmentSEC Form 419 December 2006Common Stock · traded 18 December 2006 · filed 19 December 2006
- ▼ sold on the open market 1,163 shares of Pharmaceutical Product DevelopmentSEC Form 419 December 2006Common Stock · traded 18 December 2006 · filed 19 December 2006
- ▼ sold on the open market 1,208 shares of Pharmaceutical Product DevelopmentSEC Form 419 December 2006Common Stock · traded 18 December 2006 · filed 19 December 2006
- ▼ sold on the open market 400 shares of Pharmaceutical Product DevelopmentSEC Form 419 December 2006Common Stock · traded 18 December 2006 · filed 19 December 2006
- ▼ sold on the open market 100 shares of Pharmaceutical Product DevelopmentSEC Form 419 December 2006Common Stock · traded 18 December 2006 · filed 19 December 2006
- exercised options over 53,333 shares of Pharmaceutical Product Development (a derivative holding)SEC Form 46 November 2006Stock Options (to buy) · traded 2 November 2006 · filed 6 November 2006
- exercised options over 42,500 shares of Pharmaceutical Product Development (a derivative holding)SEC Form 46 November 2006Stock Options (to buy) · traded 2 November 2006 · filed 6 November 2006
- exercised options over 53,333 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- exercised options over 42,500 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 400 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 1,300 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 100 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 300 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 608 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 200 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 500 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 192 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 500 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 200 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 1,000 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 400 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 900 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 700 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 400 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 566 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 900 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 1,100 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 1,634 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 1,000 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 400 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 1,300 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 800 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 300 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 200 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 700 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 700 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 1,000 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 600 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 400 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 100 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 700 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 8,600 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 1,900 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 1,900 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 1,886 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 9,847 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 3,873 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 2,225 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 1,853 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 1,224 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 2,000 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 2,500 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 910 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 2,925 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 1,896 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 3,200 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 3,400 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 9,550 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 3,144 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 1,350 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 1,650 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 100 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 100 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 100 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 1,400 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 600 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 1,300 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 400 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 600 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 100 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 1,300 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 700 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 300 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 680 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 2,100 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 1,720 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 100 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- ▼ sold on the open market 200 shares of Pharmaceutical Product DevelopmentSEC Form 46 November 2006Common Stock · traded 2 November 2006 · filed 6 November 2006
- exercised options over 80,000 shares of Pharmaceutical Product Development (a derivative holding)SEC Form 423 May 2006Stock Options (to buy) · traded 22 May 2006 · filed 23 May 2006
- exercised options over 80,000 shares of Pharmaceutical Product DevelopmentSEC Form 423 May 2006Common Stock · traded 22 May 2006 · filed 23 May 2006
- ▼ sold on the open market 20,000 shares of Pharmaceutical Product DevelopmentSEC Form 423 May 2006Common Stock · traded 22 May 2006 · filed 23 May 2006
- ▼ sold on the open market 12,500 shares of Pharmaceutical Product DevelopmentSEC Form 423 May 2006Common Stock · traded 22 May 2006 · filed 23 May 2006
- ▼ sold on the open market 10,000 shares of Pharmaceutical Product DevelopmentSEC Form 423 May 2006Common Stock · traded 22 May 2006 · filed 23 May 2006
- ▼ sold on the open market 12,500 shares of Pharmaceutical Product DevelopmentSEC Form 423 May 2006Common Stock · traded 22 May 2006 · filed 23 May 2006
- ▼ sold on the open market 5,000 shares of Pharmaceutical Product DevelopmentSEC Form 423 May 2006Common Stock · traded 22 May 2006 · filed 23 May 2006
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.